A great deal of research is being conducted on treatments for FH and lowering LDL levels. The appropriate treatment is determined on an individual basis through consultation between the healthcare provider and the patient.
In 2025, a review was conducted as part of the update to the European directive. Figure 2 shows the effect of various treatments on LDL. In FH, combination therapy is generally used.
A 20-year follow-up study conducted at Amsterdam UMC shows a positive effect of treatment for FH patients. Among treated children, the incidence of cardiovascular disease and mortality drops significantly to nearly 0%. For FH patients, it is important to start the appropriate treatment in a timely manner. This is due to prolonged exposure to elevated LDL levels (see also risks).
For dietary and lifestyle advice, information is available at:
A calcium score (or CT-calcium score) is a measurement of the amount of calcium in the walls of the coronary arteries of the heart, determined with a CT scan, which indicates how much arterial calcification (plaque) there is and thus is a predictor of your risk of cardiovascular diseases such as a heart attack. In FH patients, the calcium score may underestimate the risk, because they may have non-calcified plaque as a result of prolonged exposure to LDL, especially in young patients (<45 years). Treatment in FH at an early age is therefore important despite CAC scores.
Share